Abbott ramps up Libre 3 production amid shortages
Sep 20, 2024 · MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Exactech files for Chapter 11, agrees to investor buyout
Oct 30, 2024 · Dive Brief: Exactech has filed for Chapter 11 bankruptcy protection and agreed to sell its assets to existing investors, the company said Tuesday.; The bankruptcy filing follows Exactech’s failure to reach an out-of-court settlement for product liability claims brought by around 2,600 patients in response to recalls of orthopedic devices, according to a court document.
Top medtech conferences in 2025 | MedTech Dive
Oct 1, 2024 · J.P. Morgan Healthcare Conference. TBD San Francisco. The J.P. Morgan Healthcare Conference is one of the industry’s largest events. Executives from medical device, hospital and pharmaceutical companies provide insights on their recent financial performance and developments to watch in the year ahead.
Stryker adds devices to remove brain tumors, clots with Nico buy
Sep 23, 2024 · Dive Brief: Stryker has struck its fourth takeover in as many months, acquiring Nico Corporation to add minimally invasive solutions for brain tumor removal and stroke care to its portfolio.; Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
Medtech companies lay off thousands in 2024, continuing last …
Feb 12, 2024 · The latest announcements continue a top industry trend from 2023.A MedTech Dive analysis of state Worker Adjustment and Retraining Notification databases found that medical device companies announced layoffs for more than 14,000 employees between Jan. 1, 2023, and June 30, 2024.. Last year, Medtronic, Abbott, Boston Scientific and Johnson & Johnson were among a long list of companies that ...
Abbott and Dexcom are launching the first over-the-counter …
Jun 26, 2024 · The new devices could allow the companies to reach about 25 million people in the U.S. with Type 2 diabetes who don’t take insulin, 15 million people who have been diagnosed with pre-diabetes and an estimated 85 million people who have undiagnosed pre-diabetes, William Blair analyst Margaret Kaczor Andrew said in an interview.
FDA posts draft guidance on biocompatibility testing of devices
Sep 23, 2024 · Dive Brief: The Food and Drug Administration has published draft guidance detailing recommendations on biocompatibility assessments of medical devices.; The document, which the FDA released Thursday, is the regulator’s response to deficiencies it said it often sees in premarket submissions.
The number of AI medical devices has spiked in the past decade
Oct 9, 2024 · The number of medical devices with artificial intelligence technology has risen sharply in the past decade. The Food and Drug Administration has authorized 950 AI or machine learning-enabled devices as of Aug. 7, 2024, according to the agency’s database. While the FDA authorized the first AI-enabled device in 1995, the number of …